Welcome to EpilepsyU.com a social network dedicated to the epilepsy community


Data Lacking to Explain Why US Doctors Prefer Keppra to Treat Pediatric Epilepsy

Doctors have several anti-seizure options to treat epilepsy, but little data exists to show which of these treatments is best for children. Nevertheless, according to a recent study on therapies prescribed for children under 3 with epilepsy, doctors in the U.S. appear to prefer Keppra (levetiracetam) as either a first or second option for treatment.

Epilepsy drug may reverse memory loss of potential Alzheimer’s patients

A common epilepsy drug may reverse a condition that impairs memory in elderly patients and increases the risk of developing Alzheimer’s disease, suggests a study published this week in the journal NeuroImage: Clinical. The drug, atypical antiepileptic levetiracetam, reduced over-activity in the brains of patients with amnestic mild cognitive impairment (aMCI), a condition marked by abnormal memory impairment for the patient’s age. According to the Alzheimer’s Association, 10 to 20 percent of people aged 65 and older have mild cognitive impairment, and in many cases the condition is an early marker of Alzheimer’s and other dementias.

Lost Password